We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

How Can We Make Behavioral Science More Reproducible?

Article   Aug 24, 2018 | by Adam Tozer, Ph.D

 
How Can We Make Behavioral Science More Reproducible?

Adam Tozer PhD

Science Writer

@adamtozer

 
 
 

RELATED ARTICLES

'Microdosers' of LSD and Magic Mushrooms are Wiser and More Creative

Article

Researchers just ran the first ever pre-registered scientific study on the microdosing of psychedelics and found some very promising results.

READ MORE

Inflamyloid: What Is It and Why Is It Important in Alzheimer's Disease?

Article

Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Classically, the “amyloid” hypothesis, which ties the disease’s spread to that of amyloid protein, is thought to underlie AD’s pathology. After years of mixed to negative results in clinical trials, new research is underway to investigate what role the brain’s own immune system plays in amyloid-driven disease; an “infl-amyloid” hypothesis.

READ MORE

Artificial Intelligence, Real Solutions: How AI Can Accelerate Drug Discovery

Article

The rate at which new drugs are discovered is in decline, and computer-aided drug design has not produced the radical change in the success of candidate drugs the pharma industry anticipated. Artificial intelligence (AI)-based approaches are the new hope for revolutionizing the drug discovery process. But are these, as computer-aided drug design was, an over-hyped time bomb waiting to be found out? Or is it truly a revolution on the cusp of realizing its promise?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE